The Cutaneous Spectrum of Lupus Erythematosus

被引:77
作者
Ribero, Simone [1 ]
Sciascia, Savino [2 ]
Borradori, Luca [3 ]
Lipsker, Dan [4 ]
机构
[1] Univ Turin, Sect Dermatol, Dept Med Sci, Turin, Italy
[2] Univ Turin, San Giovanni Hosp, Ctr Res Immunopathol & Rare Dis, Dept Clin & Biol Sci, Turin, Italy
[3] Univ Bern, Dept Dermatol, Inselspital, Bern, Switzerland
[4] Univ Strasbourg, Dermatol Clin, Fac Med, Strasbourg, France
关键词
Cutaneous lupus erythematosus; Dermal lupus erythematosus; Discoid lupus erythematosus; Systemic lupus erythematosus; DRUG-INDUCED LUPUS; AMICROBIAL PUSTULOSIS; OUTCOME INSTRUMENT; CIGARETTE-SMOKING; SEVERITY INDEX; DISEASE AREA; DOUBLE-BLIND; RISK-FACTOR; MANIFESTATIONS; CLASSIFICATION;
D O I
10.1007/s12016-017-8627-2
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Systemic lupus erythematosus is a complex autoimmune disease with a wide spectrum of clinical and immunopathological features. Cutaneous and articular manifestations are the most common signs in patients with systemic lupus erythematosus. We here review the pathogenesis and the new classification of cutaneous lupus erythemathosus with a discussion of the significance of the various cutaneous signs. The lesions are classified according to the level of the cellular infiltrate and tissue damage in the epidermis, dermis, and/or subcutis. Furthermore, cutaneous lesions pointing to the presence of a thrombotic vasculopathy and those due to a distinct inflammatory, neutrophilic-mediated reaction pattern are highlighted. Particular attention will be given in describing the histology of skin manifestation. Treatment options for cutaneous lupus erythemathosus have increased with the introduction of new biological therapies. However, the majority of the patients still benefit from antimalarials, which remain the cornerstone of treatment. The evaluation and management of cutaneous lupus erythemathosus patients depend on the clinical findings and associated symptoms.
引用
收藏
页码:291 / 305
页数:15
相关论文
共 92 条
[71]   High serum IFN-α activity is a heritable risk factor for systemic lupus erythematosus [J].
Niewold, T. B. ;
Hua, J. ;
Lehman, T. J. A. ;
Harley, J. B. ;
Crow, M. K. .
GENES AND IMMUNITY, 2007, 8 (06) :492-502
[72]  
Nyberg F, 1997, BRIT J DERMATOL, V136, P217
[73]   Overview of common, rare and atypical manifestations of cutaneous lupus erythematosus and histopathological correlates [J].
Obermoser, G. ;
Sontheimer, R. D. ;
Zelger, B. .
LUPUS, 2010, 19 (09) :1050-1070
[74]  
Ortiz Victoria G, 2004, Dermatol Online J, V10, P16
[75]   Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus [J].
Petri, Michelle ;
Orbai, Ana-Maria ;
Alarcon, Graciela S. ;
Gordon, Caroline ;
Merrill, Joan T. ;
Fortin, Paul R. ;
Bruce, Ian N. ;
Isenberg, David ;
Wallace, Daniel J. ;
Nived, Ola ;
Sturfelt, Gunnar ;
Ramsey-Goldman, Rosalind ;
Bae, Sang-Cheol ;
Hanly, John G. ;
Sanchez-Guerrero, Jorge ;
Clarke, Ann ;
Aranow, Cynthia ;
Manzi, Susan ;
Urowitz, Murray ;
Gladman, Dafna ;
Kalunian, Kenneth ;
Costner, Melissa ;
Werth, Victoria P. ;
Zoma, Asad ;
Bernatsky, Sasha ;
Ruiz-Irastorza, Guillermo ;
Khamashta, Munther A. ;
Jacobsen, Soren ;
Buyon, Jill P. ;
Maddison, Peter ;
Dooley, Mary Anne ;
van vollenhoven, Ronald F. ;
Ginzler, Ellen ;
Stoll, Thomas ;
Peschken, Christine ;
Jorizzo, Joseph L. ;
Callen, Jeffrey P. ;
Lim, S. Sam ;
Fessler, Barri J. ;
Inanc, Murat ;
Kamen, Diane L. ;
Rahman, Anisur ;
Steinsson, Kristjan ;
Franks, Andrew G., Jr. ;
Sigler, Lisa ;
Hameed, Suhail ;
Fang, Hong ;
Ngoc Pham ;
Brey, Robin ;
Weisman, Michael H. .
ARTHRITIS AND RHEUMATISM, 2012, 64 (08) :2677-2686
[76]   Comparison of histopathologic-clinical characteristics of Jessner's lymphocytic infiltration of the skin and lupus erythematosus tumidus:: Multicenter study of 46 cases [J].
Remy-Leroux, Valerie ;
Leonard, Fabienne ;
Lambert, Daniel ;
Wechsler, Janine ;
Cribier, Bernard ;
Thomas, Pierre ;
Adamski, Henri ;
Marguery, Marie-Claude ;
Aubin, Franois ;
Leroy, Dominique ;
Bernard, Philippe .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2008, 58 (02) :217-223
[77]   A 4-year observation in lupus nephritis patients treated with an intensified B-lymphocyte depletion without immunosuppressive maintenance treatment-Clinical response compared to literature and immunological re-assessment [J].
Roccatello, Dario ;
Sciascia, Savino ;
Baldovino, Simone ;
Rossi, Daniela ;
Alpa, Mirella ;
Naretto, Carla ;
Di Simone, Debora ;
Simoncini, Matteo ;
Menegatti, Elisa .
AUTOIMMUNITY REVIEWS, 2015, 14 (12) :1123-1130
[78]   THE NEW CUTANEOUS MUCINOSES - A REVIEW WITH AN UP-TO-DATE CLASSIFICATION OF CUTANEOUS MUCINOSES [J].
RONGIOLETTI, F ;
REBORA, A .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1991, 24 (02) :265-270
[79]   Lupus erythematosus: systemic and cutaneous manifestations [J].
Rothfield, Naomi ;
Sontheimer, Richard D. ;
Bernstein, Megan .
CLINICS IN DERMATOLOGY, 2006, 24 (05) :348-362
[80]   Drug-induced lupus [J].
Rubin, Robert L. .
EXPERT OPINION ON DRUG SAFETY, 2015, 14 (03) :361-378